ClinicalTrials HQ

Shu Wang

Shu Wang

Explore linked clinical trials.

8 results ยท Page 1 of 1

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Chemotherapy Combined With Targeted Therapy for High-risk HER2 Positive and Lymph Node Negative Early Breast CancerHER2-positive Breast CancerRecruitingNot stated2024-12-09NCT06722612
Four Cycles Taxane With Trastuzumab and Pertuzumab Neoadjuvant Therapy Among Low Risk HER2 Positive PatientsHER2-positive Breast CancerRecruitingNot stated2024-12-09NCT06722599
Adjuvant Therapy for Intermediate Risk HER2 Positive, Lymph Node Negative Early Breast Cancer With Chemotherapy Combined Target TherapyHER2-positive Breast CancerRecruitingNot stated2024-12-02NCT06711068
Taxane Combined Targeted Therapy for Low-risk HER2 Positive and Lymph Node Negative Breast CancerHER2-positive Breast CancerRecruitingNot stated2024-12-02NCT06711055
Different Methods of Capecitabine in Patients With Non-PCR After Neoadjuvant Therapy for TNBCNeoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder, triple-negative breast carcinomaRecruitingNot stated2024-11-25NCT06700382
De-escalation of Neoadjuvant Chemotherapy Regimens With Targeted Therapy Among HER2 Positive PatientsHER2-positive Breast CancerRecruitingNot stated2024-11-25NCT06700369
Adjuvant Therapy Choice for Non-pCR HER2 Positive Early Breast Cancer After Neoadjuvant TherapyHER2-positive Breast CancerRecruitingNot stated2024-11-20NCT06693037
Adjuvant Therapy With Neratinib in HER2 Positive Early Breast CancerHER2-positive Breast CancerRecruitingNot stated2024-11-20NCT06693024